PMID- 2971638
OWN - NLM
STAT- MEDLINE
DCOM- 19881109
LR  - 20190510
IS  - 0910-5050 (Print)
IS  - 1876-4673 (Electronic)
IS  - 0910-5050 (Linking)
VI  - 79
IP  - 7
DP  - 1988 Jul
TI  - Expression of CR2 (C3d receptor) on the cell membranes of adult T cell leukemia.
PG  - 805-8
AB  - MT-2 cells, which produce human T-cell lymphotropic virus type I (HTLV-I), are 
      known to have a complement receptor. We have established that the complement 
      receptor is CR2 which binds C3d on immune complexes but not CR1. CR2 was also 
      detected on ATL-3I cells but no complement receptor was detected on ATL-1K cells 
      which lack ATL antigen (ATLA). Since CR2 is not detectable on normal T 
      lymphocytes, the presence of CR2 on some ATL cells might suggest that ATL cells 
      were derived from a particular minor lineage of T cells, or HTLV-I has a capacity 
      to induce CR2, which has been demonstrated to be an a-type growth factor for B 
      lymphocytes and to be a receptor for Epstein-Barr virus.
FAU - Kai, C
AU  - Kai C
AD  - Department of Microbiology, Fukuoka University School of Medicine.
FAU - Okada, N
AU  - Okada N
FAU - Okada, H
AU  - Okada H
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - Japan
TA  - Jpn J Cancer Res
JT  - Japanese journal of cancer research : Gann
JID - 8509412
RN  - 0 (Antigens, Differentiation, B-Lymphocyte)
RN  - 0 (HTLV-I Antigens)
RN  - 0 (Receptors, Complement)
RN  - 0 (Receptors, Complement 3d)
SB  - IM
MH  - Antigens, Differentiation, B-Lymphocyte/*analysis
MH  - HTLV-I Antigens/analysis
MH  - HTLV-I Infections/*immunology
MH  - Humans
MH  - Leukemia-Lymphoma, Adult T-Cell/*immunology
MH  - Receptors, Complement/*analysis
MH  - Receptors, Complement 3d
MH  - Rosette Formation
PMC - PMC5917600
EDAT- 1988/07/01 00:00
MHDA- 1988/07/01 00:01
PMCR- 1988/07/01
CRDT- 1988/07/01 00:00
PHST- 1988/07/01 00:00 [pubmed]
PHST- 1988/07/01 00:01 [medline]
PHST- 1988/07/01 00:00 [entrez]
PHST- 1988/07/01 00:00 [pmc-release]
AID - CAE805 [pii]
AID - 10.1111/j.1349-7006.1988.tb00039.x [doi]
PST - ppublish
SO  - Jpn J Cancer Res. 1988 Jul;79(7):805-8. doi: 10.1111/j.1349-7006.1988.tb00039.x.